Bulletin
Investor Alert

London Markets Open in:

Sanofi S.A.

PAR: FR:SAN

GO

SAN
/zigman2/quotes/206928357/delayed

86.48

Change

-1.71 -1.94%

Volume

Volume 4.27m

Nov 30, 2022, 5:37 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206928357/delayed

Previous close

88.19

86.48

Change

-1.71 -1.94%

Day low

Day high

€85.18

€88.13

Open
Open: 87.83

52 week low

52 week high

€76.45

€106.08

Open

Market cap

€111.05B

Average volume

1.89M

P/E ratio

16.40

Rev. per Employee

€421,366

EPS

5.27

Dividend

3.33

Div yield

3.85%

Ex dividend date

5/6/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/fr/san

MarketWatch News on SAN

  1. GSK, Sanofi and Haleon slump on worries over Zantac litigation

    6:18 a.m. Aug. 11, 2022

    - Steve Goldstein

  2. Regeneron to pay up to $1.1 bln plus royalties to buy Sanofi's stake in their Libtayo collaboration

    6:38 a.m. June 2, 2022

    - Tomi Kilgore

  3. Loading more headlines...
/news/nonmarketwatch/company/fr/san

Other News on SAN

  1. Big Drugmakers Pay Big Prices for Promising Biotechs

    7:12 a.m. Jan. 23, 2018

    - The Wall Street Journal Interactive Edition

  2. Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

    9:54 a.m. Jan. 22, 2018

    - The Wall Street Journal Interactive Edition

  3. Philippines Probes Dengue Vaccination Drive That Went Ahead Despite Warnings

    11:03 a.m. Dec. 18, 2017

    - The Wall Street Journal Interactive Edition

  4. FDA Panel Expands Flu Vaccine

    8:31 p.m. Feb. 27, 2013

    - The Wall Street Journal Interactive Edition

  5. Many Past Espionage Cases Had Links to China

    11:28 a.m. Feb. 21, 2013

    - The Wall Street Journal Interactive Edition

  6. French Stock Benchmark Regains Its Spring

    7:55 p.m. Feb. 29, 2012

    - The Wall Street Journal Interactive Edition

  7. FDA Restricts Use of Multaq

    3:49 p.m. Dec. 19, 2011

    - The Wall Street Journal Interactive Edition

  8. In 2012, Slow Return to European Stocks

    9:26 p.m. Dec. 18, 2011

    - The Wall Street Journal Interactive Edition

  9. Sanofi Profit Climbs 26%

    2:32 p.m. Nov. 3, 2011

    - The Wall Street Journal Interactive Edition

  10. Sanofi Offers Bonuses to Retain Genzyme Scientists

    8:44 a.m. April 28, 2011

    - The Wall Street Journal Interactive Edition

  11. Roche Sales Fall 9%

    3:08 p.m. April 14, 2011

    - The Wall Street Journal Interactive Edition

  12. Key Drugs Boost AstraZeneca

    4:17 a.m. July 29, 2010

    - The Wall Street Journal Interactive Edition

  13. Corporate Watch

    9:16 p.m. April 6, 2010

    - The Wall Street Journal Interactive Edition

  14. Sanofi Settles More Patent Suits

    6:27 a.m. April 6, 2010

    - The Wall Street Journal Interactive Edition

  15. Earnings Watch

    7:36 p.m. Feb. 10, 2010

    - The Wall Street Journal Interactive Edition

  16. Key Drug Sales, Vaccines Boost Sanofi

    10:13 a.m. Feb. 10, 2010

    - The Wall Street Journal Interactive Edition

  17. Energy Firms Lead European Markets

    12:45 p.m. Dec. 21, 2009

    - The Wall Street Journal Interactive Edition

  18. Bristol-Myers to Split Off Mead

    7:00 a.m. Nov. 16, 2009

    - The Wall Street Journal Interactive Edition

  19. Weak Data Weigh Down Europe's Indexes

    11:45 a.m. Sept. 1, 2009

    - The Wall Street Journal Interactive Edition

  20. European Shares Follow Asia Lower

    7:06 p.m. Aug. 31, 2009

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...
/news/pressrelease/company/fr/san

Press Releases on SAN

No News currently available for SAN

Rates »

Link to MarketWatch's Slice.